文献速递肝病消化道肿瘤与早癌

肝硬化与肝细胞癌基因突变全景

The landscape of gene mutations in cirrhosis and hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2020-02-08

综述总结基因组测序技术进展下肝硬化和肝细胞癌基因突变的研究图景,阐明慢性肝病(多为肝硬化阶段)中渐进突变积累与达尔文克隆选择驱动肿瘤发生,并讨论驱动突变与乘客突变在追踪肿瘤演化中的作用,提示对检测、诊断和治疗的潜在意义。

要点

  • 慢性肝病(多为肝硬化阶段)渐进积累突变,是肝细胞癌发生的重要基础。
  • 肝内达尔文选择保留优势克隆的驱动突变,并留下可追踪肿瘤演化的乘客突变。
  • 基因组测序进展推动肝硬化向肝细胞癌演变的突变图景刻画。

核心结论

  • 肝硬化阶段渐进积累的突变经达尔文选择形成优势克隆,是肝细胞癌发生的关键过程。
  • 理解特定突变的成因及其组合方式,是理解、预防和应对肝癌的核心问题。
  • 基于基因组测序的突变图景有望推动肝癌检测、诊断和治疗的突破。

研究设计与样本

  • 综述,总结近期利用基因组测序技术进展开展的研究所刻画的肝硬化基因突变图景。
  • 聚焦肝硬化中尤其通往肝细胞癌发展的基因突变。

主要发现

  • 慢性肝病(多为肝硬化阶段)导致渐进突变积累,可驱动癌症发生。
  • 肝内达尔文过程选择携带驱动突变的优势克隆,并留下可用于追踪肿瘤演化的乘客突变。
  • 近期研究依托基因组测序技术进展刻画了肝硬化与肝细胞癌的基因突变图景。

临床怎么用

  • 从突变积累与克隆选择角度理解肝硬化向肝细胞癌演变的生物学过程。
  • 关注基因组测序进展对未来肝癌检测、诊断与治疗策略的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic liver disease and primary liver cancer are a massive global problem, with a future increase in incidences predicted. The most prevalent form of primary liver cancer, hepatocellular carcinoma, occurs after years of chronic liver disease. Mutations in the genome are a causative and defining feature of all cancers. Chronic liver disease, mostly at the cirrhotic stage, causes the accumulation of progressive mutations which can drive cancer development. Within the liver, a Darwinian process selects out dominant clones with selected driver mutations but also leaves a trail of passenger mutations which can be used to track the evolution of a tumour. Understanding what causes specific mutations and how they combine with one another to form cancer is a question at the heart of understanding, preventing and tackling liver cancer. Herein, we review the landscape of gene mutations in cirrhosis, especially those paving the way toward hepatocellular carcinoma development, that have been characterised by recent studies capitalising on technological advances in genomic sequencing. With these insights, we are beginning to understand how cancers form in the liver, particularly on the background of chronic liver disease. This knowledge may soon lead to breakthroughs in the way we detect, diagnose and treat this devastating disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Müller M, Bird TG, Nault JC, et al. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. J Hepatol. 2020. PMID: 32044402. doi:10.1016/j.jhep.2020.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。